Patrick Sulem
7Patents
3h-index
10Co-inventors
43Inventor score
Filing activity: Feb 7, 2008 → Dec 11, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8367333B2 | Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction | Emerging Cross-Sectional Technologies | 4 | Active |
| US8828657B2 | Susceptibility variants for lung cancer | Chemistry; Metallurgy | 4 | Active |
| US8951735B2 | Genetic variants for breast cancer risk assessment | Emerging Cross-Sectional Technologies | 3 | Active |
| US8580501B2 | Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | Emerging Cross-Sectional Technologies | 0 | Active |
| US8808985B2 | Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm | Chemistry; Metallurgy | 0 | Active |
| US8697360B2 | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition | Emerging Cross-Sectional Technologies | 0 | Active |
| US8865400B2 | Genetic variants contributing to risk of prostate cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.